<?xml version="1.0" encoding="UTF-8"?>
<!-- このサイトマップは、2026年8月19日の12:43 AMに、WordPress 用のオリジナル SEO プラグイン All in One SEO v5.0.0.1により動的生成されました。 -->

<?xml-stylesheet type="text/xsl" href="https://infojuggle.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>InfoJuggle</title>
		<link><![CDATA[https://infojuggle.com]]></link>
		<description><![CDATA[InfoJuggle]]></description>
		<lastBuildDate><![CDATA[Tue, 11 Aug 2026 10:15:48 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://infojuggle.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://infojuggle.com/]]></guid>
			<link><![CDATA[https://infojuggle.com/]]></link>
			<title>InfoJuggle　インフォジャグル</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 10:15:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/nxera-pharma-4565-pipeline-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/nxera-pharma-4565-pipeline-analysis-2026/]]></link>
			<title>ネクセラ4565｜黒字転換とロイヤリティ帳簿</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 23:51:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/gni-group-2160-pipeline-rnpv-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/gni-group-2160-pipeline-rnpv-analysis-2026/]]></link>
			<title>GNI2160｜F351承認と買収再編の実像</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 17:25:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/oncolys-biopharma-4588-pipeline-research-202605/]]></guid>
			<link><![CDATA[https://infojuggle.com/oncolys-biopharma-4588-pipeline-research-202605/]]></link>
			<title>オンコリス4588 薬価930万円と8/21発売の解剖</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/three-d-matrix-7777-pipeline-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/three-d-matrix-7777-pipeline-analysis-2026/]]></link>
			<title>スリー・ディー・マトリックス（7777）パイプライン分析｜初の通期黒字とrNPV試算</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/sanbio-4592-pipeline-analysis-aucugo-rnpv-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/sanbio-4592-pipeline-analysis-aucugo-rnpv-2026/]]></link>
			<title>サンバイオ（4592）分析：アクーゴ薬価収載とrNPV試算</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/tims-4891-biopharma-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/tims-4891-biopharma-pipeline-analysis/]]></link>
			<title>ティムス(4891)脳梗塞新薬ORION試験の全貌</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/carna-biosciences-4572-btk-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/carna-biosciences-4572-btk-rnpv-analysis/]]></link>
			<title>カルナバイオ(4572) BTK阻害薬の実力をrNPVで検証</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/stemrim-4599-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/stemrim-4599-pipeline-analysis/]]></link>
			<title>ステムリム（4599）徹底調査：9月ダブル速報が転換点</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/prismbiolab-206a-pipeline-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/prismbiolab-206a-pipeline-research/]]></link>
			<title>PRISM BioLab（206A）大手5社提携の創薬力を徹底分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/biopharma-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/biopharma-research/]]></link>
			<title>バイオ医薬品 パイプライン調査レポート一覧</title>
			<pubDate><![CDATA[Mon, 17 Aug 2026 12:21:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/renascience-4889-rnpv-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/renascience-4889-rnpv-pipeline-analysis/]]></link>
			<title>レナサイエンス4889｜XPRIZE撤退後の実力</title>
			<pubDate><![CDATA[Mon, 17 Aug 2026 12:20:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/delta-fly-pharma-4598-rnpv-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/delta-fly-pharma-4598-rnpv-pipeline-analysis/]]></link>
			<title>デルタフライファーマ(4598) rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/cuorips-4894-ips-cardiomyocyte-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/cuorips-4894-ips-cardiomyocyte-rnpv-analysis/]]></link>
			<title>クオリプス(4894) iPS心筋シート承認とrNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/perseus-proteomics-4882-tfr1-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/perseus-proteomics-4882-tfr1-rnpv-analysis/]]></link>
			<title>ペルセウスプロテオミクス(4882) TfR1抗体rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/canbas-4575-cbp501-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/canbas-4575-cbp501-rnpv-analysis/]]></link>
			<title>キャンバス(4575) 免疫着火剤CBP501 rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:53:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/cyfuse-biomedical-4892-3d-bioprinting-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/cyfuse-biomedical-4892-3d-bioprinting-rnpv-analysis/]]></link>
			<title>サイフューズ(4892) 3Dバイオプリント再生医療rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/noile-immune-4893-prime-cart-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/noile-immune-4893-prime-cart-rnpv-analysis/]]></link>
			<title>ノイルイミューン(4893) PRIME CAR-T rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/chordia-therapeutics-190a-clk-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/chordia-therapeutics-190a-clk-rnpv-analysis/]]></link>
			<title>コーディアセラピューティクス(190A) CLK阻害剤rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/heartseed-219a-ips-cardiomyocyte-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/heartseed-219a-ips-cardiomyocyte-rnpv-analysis/]]></link>
			<title>ハートシード(219A) iPS心筋球rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/kringle-pharma-4884-hgf-sci-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/kringle-pharma-4884-hgf-sci-rnpv-analysis/]]></link>
			<title>クリングルファーマ(4884) HGF脊髄損傷rNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/chiome-bioscience-4583-antibody-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/chiome-bioscience-4583-antibody-rnpv-analysis/]]></link>
			<title>カイオム(4583)抗体パイプラインrNPV分析</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:52:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/healios-4593-pipeline-analysis-ards-ipsc-nk/]]></guid>
			<link><![CDATA[https://infojuggle.com/healios-4593-pipeline-analysis-ards-ipsc-nk/]]></link>
			<title>ヘリオス4593｜ARDS承認申請の関門を検証</title>
			<pubDate><![CDATA[Sun, 16 Aug 2026 12:49:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/jdsc-4418-equity-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/jdsc-4418-equity-analysis/]]></link>
			<title>JDSC4418決算｜AI事業45億→今期70億へ+55%</title>
			<pubDate><![CDATA[Sat, 15 Aug 2026 08:56:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/datasection-3905-q1-fy2027-ai-datacenter/]]></guid>
			<link><![CDATA[https://infojuggle.com/datasection-3905-q1-fy2027-ai-datacenter/]]></link>
			<title>データセクション3905｜1Q決算とデータセンター事業精査</title>
			<pubDate><![CDATA[Sat, 15 Aug 2026 00:36:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/growth-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/growth-research/]]></link>
			<title>グロース株（AI） 調査レポート一覧</title>
			<pubDate><![CDATA[Sat, 15 Aug 2026 00:33:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/microwave-chemical-9227-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/microwave-chemical-9227-growth-analysis/]]></link>
			<title>マイクロ波化学9227｜黒字化計画と自己資本8.6%</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 11:20:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/refinverse-7375-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/refinverse-7375-growth-analysis/]]></link>
			<title>リファインバース7375決算｜最高益でも計画未達</title>
			<pubDate><![CDATA[Fri, 14 Aug 2026 10:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/machinery-research/]]></link>
			<title>機械株 調査レポート一覧</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 14:28:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/chiyoda-6366-offshore-energy-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/chiyoda-6366-offshore-energy-research/]]></link>
			<title>千代田化工(6366)1Q｜受注進捗10%と優先株</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 14:28:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/auto-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/auto-research/]]></link>
			<title>自動車株リサーチ</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 09:53:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/honda-7267-auto-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/honda-7267-auto-research/]]></link>
			<title>ホンダ(7267)決算分析｜二輪が支える実質PER8倍</title>
			<pubDate><![CDATA[Tue, 11 Aug 2026 09:53:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/ibiden-4062-semiconductor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/ibiden-4062-semiconductor-analysis-2026/]]></link>
			<title>イビデン1Q｜前受金735億円と営業利益+52%</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 16:18:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/ushio-6925-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/ushio-6925-machinery-research/]]></link>
			<title>ウシオ電機(6925)1Q決算｜営業利益4.1倍の中身</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 16:04:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/shinden-hightex-3131-memory-distributor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/shinden-hightex-3131-memory-distributor-analysis-2026/]]></link>
			<title>シンデン3131｜特別配当100円の意味</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 22:36:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/semiconductor-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/semiconductor-research/]]></link>
			<title>半導体銘柄 調査レポート一覧</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 22:32:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/minato-holdings-6862-memory-module-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/minato-holdings-6862-memory-module-analysis-2026/]]></link>
			<title>ミナトHD 6862｜営業益35倍の中身を検証</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 16:28:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/modec-6269-offshore-energy-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/modec-6269-offshore-energy-research/]]></link>
			<title>三井海洋開発(6269)2Q｜最高益と受注残減</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 12:53:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/kawada-3443-construction-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/kawada-3443-construction-research/]]></link>
			<title>川田テクノロジーズ(3443)1Q｜受注残1.4年と持分法49%</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 12:05:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/fujikura-5803-trading-metals-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/fujikura-5803-trading-metals-research/]]></link>
			<title>フジクラ5803｜1Q営業益2.6倍、PER26倍の意味</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 23:33:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/harmonic-drive-6324-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/harmonic-drive-6324-machinery-research/]]></link>
			<title>ハーモニック(6324)1Q決算｜受注+56%と上方修正</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 13:14:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mazda-7261-auto-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mazda-7261-auto-research/]]></link>
			<title>マツダ(7261)決算分析｜実質PER3.7倍の中身</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 13:16:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mitsubishi-heavy-7011-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mitsubishi-heavy-7011-machinery-research/]]></link>
			<title>三菱重工(7011)1Q決算分析｜GTCCと上方修正余地</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 11:36:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/jgc-1963-offshore-energy-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/jgc-1963-offshore-energy-research/]]></link>
			<title>日揮HD(1963)1Q｜増益でも受注進捗7%</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 12:49:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/toyota-7203-auto-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/toyota-7203-auto-research/]]></link>
			<title>トヨタ(7203)決算分析｜上方修正の中身</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 10:51:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mitsui-co-8031-trading-metals-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mitsui-co-8031-trading-metals-research/]]></link>
			<title>三井物産8031｜1Q53%増益と2000億円自社株買いを解剖</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 10:44:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/construction-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/construction-research/]]></link>
			<title>建設株リサーチ</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 12:05:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/marubeni-8002-trading-metals-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/marubeni-8002-trading-metals-research/]]></link>
			<title>丸紅8002｜1Q21%増益と1000億円自社株買いを解剖</title>
			<pubDate><![CDATA[Mon, 03 Aug 2026 16:36:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mitsubishi-corp-8058-trading-metals-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mitsubishi-corp-8058-trading-metals-research/]]></link>
			<title>三菱商事8058｜1Q純利益47%増でも進捗27%の読み方</title>
			<pubDate><![CDATA[Mon, 03 Aug 2026 16:22:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/exawizards-4259-equity-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/exawizards-4259-equity-analysis/]]></link>
			<title>エクサウィザーズ4259｜1Q+41%・今期156億計画</title>
			<pubDate><![CDATA[Fri, 14 Aug 2026 16:12:39 +0000]]></pubDate>
		</item>
				</channel>
</rss>
